trending Market Intelligence /marketintelligence/en/news-insights/trending/9dyY8pqJXwNyiP8SAfzkRg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Tandem Diabetes closes common stock, warrants offering

Blog

JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition


Tandem Diabetes closes common stock, warrants offering

Tandem Diabetes Care Inc. closed its public offering of 4,630,000 common shares as well as series A and series B warrants at $3.50 apiece with expected net proceeds of about $14.8 million.

Each common share comes bundled with the two warrants, each to purchase an additional stock in the company for $3.50 apiece.

The net proceeds will be used for working capital and general corporate purposes.

Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering. National Securities Corp. acted as co-manager.